Parkinson’s Disease
167 results.
LONDON (April 3, 2024) — Results from a one-year, phase 2 clinical trial of the Type 2 diabetes drug lixisenatide suggest that the treatment may…
GRAND RAPIDS, Mich. (March 6, 2024) — Van Andel Institute’s free Public Lecture Series returns March 20. This year’s lineup tackles topics such as cancer and nutrition,…
LONDON (Feb. 23, 2024) — Cure Parkinson’s and Van Andel Institute are delighted to announce funding for a Phase 2 clinical trial…
A “blockbuster” weight loss medication hailed as the “2023 Breakthrough of the Year” by Science also may have game-changing implications for Parkinson’s…
GRAND RAPIDS (Mich.) Sept. 29, 2023 — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Dr. Natasha Fothergill-Misbah, Research…
For more than a decade, Matt Cook has worked to empower communities. As the vice president of community relations at Lake Michigan Credit Union…
Parkinson’s disease is a challenging diagnosis. It requires adjustments to day-to-day life and a change in regular habits. But for Richard Cebelak, Parkinson’s would not…
Copenhagen, Denmark (August 28, 2023) — A one-year, phase 2 clinical trial of Type 2 diabetes drug lixisenatide has reported positive early results, which indicate…